Malabsorption News

SAN DIEGO — In a Healio video exclusive, Andres Acosta, MD, PhD, outlines research presented at Digestive Disease Week 2022 that focused on the relationship between gastric function and the regulation of food intake.

The FDA has issued a draft guidance for sponsors developing drugs as adjunctive treatment to a gluten-free diet in adults with celiac disease.

May is Celiac Disease Awareness Month, and the Celiac Disease Foundation — along with those in the celiac community — have dedicated the month to raising awareness and funds for critical disease research and advocacy efforts.

Research suggests the gut microbiome plays a role in response to cancer immunotherapy, according to a study published in Nature Medicine.

In this Healio video exclusive, Eric D. Shah, MD, MBA, of Dartmouth-Hitchcock Medical Center in New Hampshire, discusses his latest “disruptive” research to improve patient care in gastroenterology.

The Microbiome Health Index for post-Antibiotic dysbiosis was a promising biomarker for predicting antibiotic dysbiosis and subsequent microbiome restoration, according to research published in Frontiers of Microbiology.

LAS VEGAS – In a video exclusive with Healio Gastroenterology, Colin W. Howden, MD, FACG, of the University of Tennessee, outlined emerging study data on acid-peptic disorders.

This award goes to a gastroenterologist or hepatologist who consistently pushed the gastroenterology field forward through innovative treatments, practice management, patient care or research.

Healio Gastroenterology presents the following report on the top stories from UEG Week 2021.

Critically ill patients who required mechanical ventilation and received the probiotic Lactobacillus rhamnosus GG were as likely to develop ventilator-associated pneumonia as those who received placebo, a randomized clinical trial showed.